IDXXIDEXX LABORATORIES INC /DE

Nasdaq idexx.com


$ 489.24 $ -5.02 (-1.02 %)    

Thursday, 25-Apr-2024 15:59:59 EDT
QQQ $ 429.36 $ 8.34 (1.98 %)
DIA $ 380.88 $ -3.56 (-0.93 %)
SPY $ 507.81 $ 5.55 (1.11 %)
TLT $ 87.78 $ -0.61 (-0.69 %)
GLD $ 215.92 $ 1.27 (0.59 %)
$ 494.26
$ 494.35
$ 0.00 x 0
$ 0.00 x 0
$ 480.03 - $ 494.35
$ 372.50 - $ 583.39
493,145
na
41.51B
$ 1.26
$ 49.12
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-22-2024 12-31-2023 10-K
2 11-01-2023 09-30-2023 10-Q
3 08-01-2023 06-30-2023 10-Q
4 05-02-2023 03-31-2023 10-Q
5 02-16-2023 12-31-2022 10-K
6 11-01-2022 09-30-2022 10-Q
7 08-02-2022 06-30-2022 10-Q
8 05-04-2022 03-31-2022 10-Q
9 02-16-2022 12-31-2021 10-K
10 11-02-2021 09-30-2021 10-Q
11 07-30-2021 06-30-2021 10-Q
12 05-04-2021 03-31-2021 10-Q
13 02-12-2021 12-31-2020 10-K
14 10-29-2020 09-30-2020 10-Q
15 07-31-2020 06-30-2020 10-Q
16 04-30-2020 03-31-2020 10-Q
17 02-14-2020 12-31-2019 10-K
18 10-31-2019 09-30-2019 10-Q
19 08-01-2019 06-30-2019 10-Q
20 05-01-2019 03-31-2019 10-Q
21 02-15-2019 12-31-2018 10-K
22 11-01-2018 09-30-2018 10-Q
23 08-01-2018 06-30-2018 10-Q
24 05-04-2018 03-31-2018 10-Q
25 02-16-2018 12-31-2017 10-K
26 10-31-2017 09-30-2017 10-Q
27 08-01-2017 06-30-2017 10-Q
28 04-28-2017 03-31-2017 10-Q
29 02-17-2017 12-31-2016 10-K
30 11-01-2016 09-30-2016 10-Q
31 08-02-2016 06-30-2016 10-Q
32 04-29-2016 03-31-2016 10-Q
33 02-17-2016 12-31-2015 10-K
34 10-28-2015 09-30-2015 10-Q
35 07-30-2015 06-30-2015 10-Q
36 04-28-2015 03-31-2015 10-Q
37 02-17-2015 12-31-2014 10-K
38 10-24-2014 09-30-2014 10-Q
39 07-25-2014 06-30-2014 10-Q
40 04-25-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 investor-activism-elanco-animal-health-settles-with-ancora-adds-new-board-members

Elanco Animal Health settles with Ancora, expanding board to 14 members, including Ancora's nominees Craig Wallace and Kath...

 jp-morgan-maintains-overweight-on-idexx-laboratories-raises-price-target-to-630

JP Morgan analyst Chris Schott maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and raises the price target from...

 barclays-maintains-overweight-on-idexx-laboratories-raises-price-target-to-655

Barclays analyst Balaji Prasad maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and raises the price target from...

 stocks-fall-as-traders-dial-back-rate-cut-bets-dollar-treasury-yields-rise-whats-driving-markets-monday

Wall Street ends week on negative note as traders revise down expectations on Fed rate cuts. Strong economic data and Fed offic...

 why-is-animal-diagnostic-focused-idexx-laboratories-stock-trading-higher-today

IDEXX Laboratories gains on Q4 2023 results. Despite challenges, Idexx demonstrates resilience in the global animal health market.

 idexx-laboratories-q4-adjusted-ps-234-beats-212-estimate-sales-90160m-beat-89125m-estimate

IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $2.34 per share which beat the analyst consensus estimate of $2...

 earnings-scheduled-for-february-5-2024

Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is estimated to report quarterly earnings at $0.26 pe...

 piper-sandler-downgrades-idexx-laboratories-to-neutral-announces-525-price-target

Piper Sandler analyst David Westenberg downgrades IDEXX Laboratories (NASDAQ:IDXX) from Overweight to Neutral and announces ...

 goldman-sachs-maintains-buy-on-idexx-laboratories-raises-price-target-to-650

Goldman Sachs analyst Nathan Rich maintains IDEXX Laboratories (NASDAQ:IDXX) with a Buy and raises the price target from $50...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION